Another candidate has hopped into the running as the potential next US FDA commissioner: Joseph Gulfo. In an interview with Medtech Insight, the former medical diagnostic industry executive and author says he would take a closer look at the recently negotiated user-fee agreements between FDA and medical-product industries to find ways to cut any unnecessary regulations and legal overreach.
Gulfo is the fourth potential Trump administration FDA commissioner candidate to make it into public view. The others include Jim O'Neill, a Silicon Valley insider who advocates ridding FDA's efficacy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?